DKK2 and cervical cancer: The rate of detection of DKK2 methylation in HPV16/18-positive patients in the cervical cancer group (66.7%) was significantly higher than that in HPV16/18-negative patients (36.0%) (χ2 = 6.279, P = 0.015).